Marsa Corporate Finance supported a French midsize biopharmaceutical company in its latest increase of share capital. The company progresses a number of proprietary programs in different clinical development stages.
Access to potent Swiss investors was a main virtue, when engaging Marsa Corporate Finance.
Andreas J. Schulze, PhD
MARSA CORPORATE FINANCE GmbH
Direkt +41 76 341 18 76